BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 28870093)

  • 1. Novel series of 1,2,4-trioxane derivatives as antimalarial agents.
    Rudrapal M; Chetia D; Singh V
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
    Vijayaraghavan S; Mahajan S
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trioxaferroquines as new hybrid antimalarial drugs.
    Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
    J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
    O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
    Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
    Rudrapal M; Chetia D
    Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Biological Evaluation of Novel 1,2,4-Trioxanes as Potential Antimalarial Agents.
    Gupta AK; Varshney K; Kumar V; Srivastava K; Pant AB; Puri SK; Saxena AK
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28207169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, molecular docking, drug-likeness, and molecular dynamics studies of 1,2,4-trioxane derivatives as novel
    Ghosh S; Chetia D; Gogoi N; Rudrapal M
    BioTechnologia (Pozn); 2021; 102(3):257-275. PubMed ID: 36606151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing novel inhibitors against falcipain-2 of Plasmodium falciparum.
    Himangini ; Pathak DP; Sharma V; Kumar S
    Bioorg Med Chem Lett; 2018 May; 28(9):1566-1569. PubMed ID: 29602682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
    Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
    Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.
    Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
    Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells.
    Reiter C; Capcı Karagöz A; Fröhlich T; Klein V; Zeino M; Viertel K; Held J; Mordmüller B; Emirdağ Öztürk S; Anıl H; Efferth T; Tsogoeva SB
    Eur J Med Chem; 2014 Mar; 75():403-12. PubMed ID: 24561670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents.
    Bekhit AA; Hassan AM; Abd El Razik HA; El-Miligy MM; El-Agroudy EJ; Bekhit Ael-D
    Eur J Med Chem; 2015 Apr; 94():30-44. PubMed ID: 25768697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer Agents.
    Tiwari MK; Coghi P; Agrawal P; Shyamlal BRK; Jun Yang L; Yadav L; Peng Y; Sharma R; Yadav DK; Sahal D; Kam Wai Wong V; Chaudhary S
    ChemMedChem; 2020 Jul; 15(13):1216-1228. PubMed ID: 32392362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, Antimalarial Activity and Docking Study of 7-Chloro-4- (2-(substituted benzylidene)hydrazineyl)quinolines.
    Kalita J; Chetia D; Rudrapal M
    Med Chem; 2020; 16(7):928-937. PubMed ID: 31385774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
    Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
    Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin.
    Cumming JN; Wang D; Park SB; Shapiro TA; Posner GH
    J Med Chem; 1998 Mar; 41(6):952-64. PubMed ID: 9526569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures.
    Hossain MI; Świtalska M; Peng W; Takashima M; Wang N; Kaiser M; Wietrzyk J; Dan S; Yamori T; Inokuchi T
    Eur J Med Chem; 2013 Nov; 69():294-309. PubMed ID: 24056020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
    Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
    Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.